These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22333640)

  • 1. [A case of breast cancer with chronic renal failure successfully treated with TC therapy as adjuvant chemotherapy].
    Oshiro C; Arai T; Kamigaki S; Matsuura M
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):265-7. PubMed ID: 22333640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Feasibility of adjuvant docetaxel plus cyclophosphamide therapy for breast cancer].
    Naito K; Oura S; Yoshimasu T; Nakamura R; Hirai Y; Kiyoi M; Miyasaka M; Okamura Y
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1913-6. PubMed ID: 20948255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety and tolerance of docetaxel (especially 75 mg/m2) with cyclophosphamide (TC therapy) as adjuvant chemotherapy for Japanese patients with operable breast cancer].
    Watanabe K; Taguchi K; Yamamoto M; Jotoku H; Tamura M
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1265-9. PubMed ID: 20647707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of acute appendicitis which occurred during chemotherapy for breast cancer].
    Oshida S; Hayashi K; Habiro T; Hatate K; Sengoku N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2417-9. PubMed ID: 24394131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast carcinoma and bone chondrosarcoma: a new syndrome?].
    Guedin P; Chasle J; Blanc-Fournier C; Lacroix J
    J Radiol; 2006 Nov; 87(11 Pt 1):1700-4. PubMed ID: 17095966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy].
    Yoneyama K; Takeshita T; Suzuki H; Morise M; Suzuki T; Kishi S; Tsutsui A; Matsumoto A
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):435-7. PubMed ID: 21403449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
    Yuan P; Xu BH; Wang JY; Ma F; Li Q; Zhang P; Fan Y; Li Q; Wang WM
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):465-8. PubMed ID: 22967451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
    Yagata H; Kajiura Y; Yamauchi H
    Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
    Jones SE; Savin MA; Holmes FA; O'Shaughnessy JA; Blum JL; Vukelja S; McIntyre KJ; Pippen JE; Bordelon JH; Kirby R; Sandbach J; Hyman WJ; Khandelwal P; Negron AG; Richards DA; Anthony SP; Mennel RG; Boehm KA; Meyer WG; Asmar L
    J Clin Oncol; 2006 Dec; 24(34):5381-7. PubMed ID: 17135639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety and tolerability of docetaxel with cyclophosphamide for early breast cancer].
    Kawabata H; Iwatani T; Makuuchi R; Miura D; Suzuki N; Nakazawa H
    Gan To Kagaku Ryoho; 2010 May; 37(5):835-9. PubMed ID: 20495312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of inflammatory breast cancer achieving pathological complete response by primary systemic therapy with CEF (cyclophosphamide, epirubicin, 5-fluorouracil) followed by docetaxel].
    Sagara Y; Rai Y; Sagara Y; Tamada S; Tsuchimochi S; Takahama T; Matsuyama Y; Ando M; Ooi Y; Sagara Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):77-80. PubMed ID: 17220675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
    Jones SE; Collea R; Paul D; Sedlacek S; Favret AM; Gore I; Lindquist DL; Holmes FA; Allison MAK; Brooks BD; Portillo RM; Vukelja SJ; Steinberg MS; Stokoe C; Crockett MW; Wang Y; Asmar L; Robert NJ; O'Shaughnessy J
    Lancet Oncol; 2013 Oct; 14(11):1121-1128. PubMed ID: 24007746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary systemic therapy in breast cancer patients (2007-2010)].
    Zapf I; Tizedes G; Pavlovics G; Kovács G; Kálmán E; Szalai G; Kövér E; Farkas R; Horváth OP
    Magy Seb; 2011 Oct; 64(5):223-8. PubMed ID: 21997525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The safety of docetaxel with cyclophosphamide (TC) therapy as adjuvant chemotherapy for Japanese women with operable breast cancer].
    Tashiro H; Sagawa T; Okada K; Kurokawa T; Soga H; Watanabe R; Yasuoka Y; Honda K; Watanabe Y; Gangi J; Akehi S; Masuda J; Nomoto M;
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):393-6. PubMed ID: 17353630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
    Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
    J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide].
    Yoshibayashi H; Ishiguro H; Takada M; Takeuchi M; Yamashiro H; Ueno T; Kato H; Yoshikawa K; Kanao S; Yamauchi C; Mikami Y; Toi M
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):987-90. PubMed ID: 18633230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.